1. 2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases. Issue 2 (7th June 2020) Authors: Taxonera, Carlos; Sagastagoitia, Iñigo; Alba, Cristina; Mañas, Norberto; Olivares, David; Rey, Enrique Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 2(2020) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis. Issue 4 (4th May 2022) Authors: Taxonera, Carlos; Fernández‐Aceñero, María Jesús; Olivares, David; Calvo, Marta; Casis, Begoña; Bermejo, Fernando; López Serrano, Pilar; Iborra, Marisa; Mesonero, Francisco; Boscá Watts, Maia; Díaz del Arco, Cristina; Vera, Isabel; Olivares, Sonsoles; Algaba, Alicia; Alba, Cristina Journal: Alimentary pharmacology & therapeutics Issue: Volume 56:Issue 4(2022) Page Start: 614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis. Issue 8 (30th June 2017) Authors: Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; Menchén, Luís; Arribas, Julia; Sierra, Mónica; Arias, Lara; Martínez-Montiel, Pilar; Juan, Alba; Iglesias, Eva; Algaba, Alicia; Manceñido, Noemí; Rivero, Montserrat; Barreiro-de Acosta, Manuel; López-Serrano, Pilar; Argüelles-Arias, Fed... Journal: Inflammatory bowel diseases Issue: Volume 23:Issue 8(2017) Page Start: 1394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis. (3rd July 2019) Authors: Taxonera, Carlos; Iborra, Marisa; Bosca-Watts, Marta Maia; Rubio, Saioa; Nantes, Óscar; Higuera, Rebeca; Bertoletti, Federico; Martínez-Montiel, Pilar; Sierra-Ausin, Mónica; Manceñido, Noemí; Lázaro Pérez-Calle, José; Algaba, Alicia; Olivares, David; Alba, Cristina Journal: Current medical research and opinion Issue: Volume 35:Number 7(2019) Page Start: 1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease. (17th February 2017) Authors: Taxonera, Carlos; Ponferrada, Ángel; Bermejo, Fernando; Riestra, Sabino; Saro, Cristina; Martín-Arranz, María Dolores; Cabriada, José Luis; Barreiro-de Acosta, Manuel; de Castro, María Luisa; López-Serrano, Pilar; Barrio, Jesús; Suarez, Cristina; Iglesias, Eva; Argüelles-Arias, Federico; Ferrer, ... Journal: Journal of Crohn's and colitis Issue: Volume 11:Number 7(2017:Jul.) Page Start: 792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease. (September 2019) Authors: Chaparro, María; Aterido, Adrià; Guerra, Iván; Iborra, Marisa; Cabriada, Jose Luis; Bujanda, Luis; Taxonera, Carlos; García-Sánchez, Valle; Marín-Jiménez, Ignacio; Barreiro-de Acosta, Manuel; Vera, Isabel; Martín-Arranz, Maria Dolores; Hernández-Breijo, Borja; Mesonero, Francisco; Sempere, Laura;... Journal: Therapeutic advances in gastroenterology Issue: Volume 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures. Issue 6 (17th May 2021) Authors: Taxonera, Carlos; Alba, Cristina; Olivares, David; Martin, María; Ventero, Alejandro; Cañas, Mercedes Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures. Issue 6 (19th August 2020) Authors: Taxonera, Carlos; Alba, Cristina; Olivares, David; Martin, María; Ventero, Alejandro; Cañas, Mercedes Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 6(2021) Page Start: 864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors. Authors' reply. Issue 3 (25th June 2020) Authors: Taxonera, Carlos; Sagastagoitia, Iñigo; Alba, Cristina; Mañas, Norberto; Olivares, David; Rey, Enrique Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 3(2020) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Meta‐analysis: Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis. Issue 6 (16th January 2023) Authors: Taxonera, Carlos; Olivares, David; López‐García, Olga N.; Alba, Cristina Journal: Alimentary pharmacology & therapeutics Issue: Volume 57:Issue 6(2023) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗